|
|
---|
Monday, March 22, 2010
Acne drug already known for many years and low cost can actually be looking for targets infected immune cells, such as the HIV virus was sleeping, before they returned and spread the infection.
The researchers from the United States says, drug antibiotic, minocycline, which has been more widely used to cope with acne, have the strength to fight HIV. If the drug is added to standard therapy in the treatment of AIDS, the result is believed to be even greater.
"Currently, the focus of experts in coping with HIV is to keep the virus remained locked in sleep. If the drugs are currently effective to prevent viral replication, minocycline is another weapon to fight the virus," said Janice Clement, professor of molecular from Johns Hopkins University School of Medicine, USA.
He added, minocycline works with the target immune cells, called T-cells, and made him unable to reproduce. Thus, HIV so difficult to spread and cause AIDS.
"It will give good results for very specific target," said Gregory Szeto, who studied the virus in the laboratory. The results of this study published in the Journal of Infectious Diseases.
The researchers from the United States says, drug antibiotic, minocycline, which has been more widely used to cope with acne, have the strength to fight HIV. If the drug is added to standard therapy in the treatment of AIDS, the result is believed to be even greater.
"Currently, the focus of experts in coping with HIV is to keep the virus remained locked in sleep. If the drugs are currently effective to prevent viral replication, minocycline is another weapon to fight the virus," said Janice Clement, professor of molecular from Johns Hopkins University School of Medicine, USA.
He added, minocycline works with the target immune cells, called T-cells, and made him unable to reproduce. Thus, HIV so difficult to spread and cause AIDS.
"It will give good results for very specific target," said Gregory Szeto, who studied the virus in the laboratory. The results of this study published in the Journal of Infectious Diseases.
Labels: health
0 Comments:
Subscribe to:
Post Comments (Atom)